Opportunistic Infections (OIs) in Patients with Hematologic Malignancies (HM) Treated with Bruton's Tyrosine Kinase (BTK) and Phosphoinositide 3 Kinase (PI3K) Inhibitors: An 8-Year Retrospective Cohort Study

Nicolas Issa, Esther Arbona-Haddad, Alexandra Nevett-Fernandez, Daniel Prestes, Alexis Liakos, Ann Woolley, Sarah Hammond, Jennifer Brown, Lindsey Baden, Francisco Marty
2017 Open Forum Infectious Diseases  
doi:10.1093/ofid/ofx163.1876 fatcat:74acqpagbvg4vjhg4apkek3tdq